8-KThe WireRoutine
Shareholder Vote
Filed Dec 16, 2021 · 4y ago · Accession 0001193125-21-358518
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- BridgeBio Pharma, Inc.
- Ticker
- BBIO
- CIK
- 1743881
- Form type
- 8-K
- Filing date
- Dec 16, 2021
- Report date
- Dec 15, 2021
- Document
- d221622d8k.htm
- Size
- 147 KB